In America, the relationship between doctors and the hegemonic pharmaceutical industry is fraught with painful, mind-numbing contradiction. There’s no better example of this than in the treatment of Post-Traumatic Stress Disorder (PTSD) among US veterans and others around the country. Drugs like Risperdal, an antipsychotic, are said to be no more effective in the treatment of PTSD than a placebo. These drugs are widely distributed to treat the symptoms of PTSD, despite allegations that they’re ineffectual in treatment of the condition.
PTSD is a disorder, characterized by extreme emotional or mental anxiety, often the result of a physical or psychological injury. When confronted with a potentially deadly situation, it’s natural for humans to feel afraid—we’ve developed pretty sophisticated fight-or-flight responses to deal with real or perceived danger. PTSD arises when that response is damaged, and the patient feels stressed or frightened even when he or she is no longer in danger. The disease disproportionately affects soldiers deployed in war zones. Very often they are in situations so dangerous that they develop the condition, and return home as shell-shocked emotional cripples. Veteran’s Affairs claims that today, almost 300,000 veterans have been diagnosed with PTSD, although the number is likely much higher due to lack of diagnosis...
Read the full article at VICE